Biopharma and academic research teams get long unattended research runs, but the launch price of $200 a run may already have risen.

Kenning's take

What it does

Kosmos is an AI research agent that reads scientific literature, analyses datasets, generates hypotheses and runs research workflows on its own over many hours. Edison Scientific, a commercial spinout of FutureHouse, now sells it to drug companies and research labs for work from target discovery through to regulatory filing. It is used on Edison's web platform and can report findings through Slack, Teams and email.

• Reads literature and analyses data autonomously
• Generates and branches hypotheses during a run
• Drug development workflows from target identification to filing
• Works through Slack, Teams and email
• Model-agnostic, uses frontier models

Who it suits. Biopharma research teams and academic scientists who want long, automated research runs.

Key facts

Category

Business tools

Made by

Edison Scientific

Released

5 November 2025

How to get it

on the Edison platform at platform.edisonscientific.com, with demos for companies; some free usage for academics at launch

Works on

Web, Slack, Microsoft Teams, email

Free plan

some free tier usage for academics, per the November 2025 launch post

Pricing

Plan	Price	Billed
Kosmos run (launch price)	$200	per run

source

FAQ

Facts from the maker's own pages and the sources listed. Checked 2026-10-11.